FDA Staff Say Trial Data Support Use Of Pfizer’s Nirmatrelvir/Ritonavir In Adults At High Risk For Severe COVID-19

Reuters (3/14, Mandowara, Leo) reports FDA “staff reviewers said on Tuesday data from Pfizer Inc’s COVID-19 drug trials support its use in adults at high risk of progressing to severe disease, bringing the pill closer to a full approval.” The agency “made...